cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients will be diagnosed as malignant tumors with cytological or histopathological diagnosis , including respiratory tract tumors, gastrointestinal tumors and reproductive system tumors; 2) Patients who have received chemotherapy in the past 1 month; 3) Aged >= 18 years; 4) Eastern Cooperative Oncology Group (ECOG) score 1 month; 5) Have certain reading ability; 6) Voluntarily agree to participate in this study and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1) Hyperthermia occurs within two weeks with a body temperature of more than 38 degrees C, or there is obvious active infection; 2) Significant cardiovascular abnormalities (e.g., myocardial infarction, superior vena cava syndrome, grade 2 or above heart disease or uncontrolled hypertension before enrollment (systolic blood pressure over 160 mmHg or diastolic blood pressure over 100mmHg); 3) Serum bilirubin is 1.5 times higher than the upper limit of the reference range of normal value; 4) The serum myoliver is 1.5 times higher than the upper limit of the reference range of normal value or myoliver clearance rate in the absence of liver metastasis; 2.5 times the upper limit of the normal value, or 5 times the upper limit of the reference range of ALT or AST in the case of liver metastasis; 6) Pregnant or lactating women; 7) Persons with mental illness or intellectual or language impairment; 8) Patients who are known to be allergic to the components used in the study; 9) Patients who are participating in other drug trials within the past month or so;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TCM syndrome score and chills and fever constitution scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Objective Response Rate;stool routine test;electrocardiogram;Blood coagulation;blood routine examination;Quality of Life scale;Biochemical;routine urine test;tumor CT enhancement; | — |
Countries
China
Contacts
Beijing University of Chinese Medicine